You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 23, 2024

LETROZOLE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Letrozole, and what generic alternatives are available?

Letrozole is a drug marketed by Accord Hlthcare, Actavis Totowa, Apotex Inc, Beijing Yiling, Carnegie, Chartwell Rx, Eugia Pharma, Fresenius Kabi Usa, Hikma, Hikma Pharms, Impax Labs, Indicus Pharma, Lannett Co Inc, Mylan, Natco Pharma Ltd, Strides Pharma, Sun Pharm Inds Ltd, Synthon Pharms, and Teva Pharms. and is included in twenty NDAs.

The generic ingredient in LETROZOLE is letrozole. There are twenty-four drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the letrozole profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Letrozole

A generic version of LETROZOLE was approved as letrozole by ACCORD HLTHCARE on June 3rd, 2011.

  Try a Trial

Drug patent expirations by year for LETROZOLE
Drug Prices for LETROZOLE

See drug prices for LETROZOLE

Drug Sales Revenue Trends for LETROZOLE

See drug sales revenues for LETROZOLE

Recent Clinical Trials for LETROZOLE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Universitaire Ziekenhuizen KU LeuvenPhase 2
Kom Op Tegen KankerPhase 2
University of MiamiPhase 2

See all LETROZOLE clinical trials

Pharmacology for LETROZOLE
Drug ClassAromatase Inhibitor
Mechanism of ActionAromatase Inhibitors
Paragraph IV (Patent) Challenges for LETROZOLE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
FEMARA Tablets letrozole 2.5 mg 020726 1 2006-03-02

US Patents and Regulatory Information for LETROZOLE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare LETROZOLE letrozole TABLET;ORAL 090934-001 Jun 3, 2011 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Sun Pharm Inds Ltd LETROZOLE letrozole TABLET;ORAL 091466-001 Jun 3, 2011 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Eugia Pharma LETROZOLE letrozole TABLET;ORAL 211717-001 Jan 11, 2019 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Beijing Yiling LETROZOLE letrozole TABLET;ORAL 205869-001 Nov 14, 2018 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.